KAT2B and cancer: As presented in Figure 2A, the expression of most BrD members significantly negatively correlated with cancer stemness across many TCGA tumor types, although only for KAT2B, KMT2A, SMARCA2, BAZ2B, SP100 and SP140, the association was highly consistent (regardless of the tumor type).